Wiley Blackwell

SHERPA: Unknown

People

  1. Schoder
    Schoder
  2. Zelenetz
    Zelenetz
  3. Kumar
    Kumar
  4. Moskowitz
    Moskowitz
  5. Yahalom
    Yahalom
  6. Hamlin
    Hamlin
  7. Noy
    Noy
  8. Palomba
    Palomba
  9. Horwitz
    Horwitz
  10. Lewis
    Lewis

Groups

  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)
  7. Hematologic Malignancies, Division of (22)
  8. Sloan Kettering Institute Postdocs (21)
  9. Center for Hematologic Malignancies (20)
  10. Body Imaging Service (19)
Search Within
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (27)
  3. Review (8)
  4. Conference Paper (5)
  5. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)

More Groups

People
  1. Steven Larson (25)
  2. Heiko Schoder (22)
  3. Ronald Finn (10)
  4. Andrew Zelenetz (8)
  5. David Straus (8)
  6. Alison Moskowitz (7)

More People

Years
  1. 2024 (7)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (7)

More Years

Publications
  1. Cancer (18)
  2. Journal of Labelled Compounds and Radiopharmaceuticals (14)
  3. Hematological Oncology (13)
  4. Journal of Magnetic Resonance Imaging (10)
  5. Journal of Surgical Oncology (5)
  6. Breast Journal (3)

More Publications

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
    Journal Article

    Torka, P.; Pederson, L. D.; Knopp, M. V.; Poon, D.; Zhang, J.; Kahl, B. S.; Higley, H. R.; Kelloff, G.; Friedberg, J. W.; Schwartz, L. H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Surgical aspects of primary hyperparathyroidism
    Review

    Perrier, N.; Lang, B. H.; Farias, L. C. B.; Poch, L. L.; Sywak, M.; Almquist, M.; Vriens, M. R.; Yeh, M. W.; Shariq, O.; Duh, Q. Y.; more...
    Journal of Bone and Mineral Research (2022)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy with 177lutethium or 90Yttrium-DOTA-TATE or -TOC in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): Results from a single institutional retrospective analysis
    Meeting Abstract

    Rubino, M.; Di Stasio, G. D.; Spada, F.; Rocca, P. A.; Laffi, A.; Fazio, N.; Bodei, L.; Grana, C. M.
    Journal of Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours
    Review

    Hicks, R. J.; Dromain, C.; de Herder, W. W.; Costa, F. P.; Deroose, C. M.; Frilling, A.; Koumarianou, A.; Krenning, E. P.; Raymond, E.; Bodei, L.; more...
    Journal of Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • (19)F MRI nanotheranostics for cancer management: Progress and prospects
    Review

    Li, Y.; Cui, J.; Li, C.; Zhou, H.; Chang, J.; Aras, O.; An, F.
    ChemMedChem (2022)

    Fulltext@MSK | Save
  • Predictive value of quantitative (18)F‐FDG‐PET‐CT radiomics analysis in 174 patients with relapsed/refractory classical Hodgkin lymphoma
    Meeting Abstract

    Driessen, J.; Zwezerijnen, G. J. C.; Schöder, H.; Moskowitz, A. J.; Kersten, M. J.; Moskowitz, C. H.; Eertink, J. J.; van de Brug, T.; de Vet, H. C. W.; Hoekstra, O. S.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • New prognostic score incorporating MTV predicts treatment failure in advanced Hodgkin lymphoma
    Meeting Abstract

    Barrington, S. F.; Kirkwood, A. A.; Pike, L. C.; Guezennec, C.; Li, H.; le Blanc, M.; Poon, D.; Knopp, M. V.; Clifton‐Hadley, L.; Laubach, C.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • CALGB 50801 (Alliance): PET adapted therapy in bulky stage I/II classic Hodgkin lymphoma (CHL)
    Meeting Abstract

    LaCasce, A. S.; Dockter, T.; Ruppert, A.; Kostakoglu, L.; Schöder, H.; Hsi, E. D.; Bogart, J. A.; Cheson, B. D.; Wagner‐Johnston, N. D.; Abramson, J. S.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save